5% accounts for 50% of pharmaceutical commodities, and chemical industry will open up the pharmaceutical market; Parallel economy and trade
The World Economic Forum was held in June+10, 65438.
Hot topic: India rises, the world turns again, and East India can make it.
The output of products with the same quality as those in the west is low, which leads to the global commodity market pattern.
Drastic changes, its raw materials have also joined the transformation industry.
The second pharmaceutical conference was hosted by Agno Pharma Company of Beijing Dongbite Technology Co., Ltd..
International forum global raw material drug procurement and outsourcing adapt to development and establish communication with external business circles.
The pharmaceutical trade exchange learning platform learns directly from foreign pharmaceutical companies through buyers and suppliers.
Industry cGMP certification experience, understand the key points of ICH Q7A implementation, and what cooperation is needed?
Seek an explanation
Interview with Zheng Zhimin, Senior Editor and Journalist of Industrial Economics Edition of Medical Economics News-Dongbi
Wu Huifang, deputy general manager of Special Science and Technology Co., Ltd. (Health Network), implements cGM in raw material industries and enterprises.
This paper makes a comprehensive summary from three aspects: practical significance, new situation and global pharmaceutical supply chain relationship.
Zheng Zhimin: Please give specific figures to illustrate the pharmaceutical tools in our API industry.
Growth trend of scale occupation
Wu Huifang:
Strictly speaking, the scope of API can be divided into broad and narrow sense.
Generally, it refers to the main components of medicinal drugs except the final product before preparation.
Precursor-like compounds, intermediates or fine chemical products are regarded as medicines.
Intermediate English Active Pharmaceutical Ingredients (API) refers to the sex drug group.
Including pharmaceutical intermediates used only in pharmacy, such as food, beverage,
The effective components of feed additives, such as carbendazim, amino acids and citric acid, are classified as raw materials.
Strictly speaking, the proportion should be classified as nutritional additives or nutritional supplements.
Element)
The production scale of API industry is 6,543,800 tons (including additives), with an average increase in output in the past three years.
The ratio reached 26%. According to the preliminary statistics in 2005, the API industry created the output value of pharmaceutical preparations of1163 billion yuan.
Chemical raw materials medicine, Chinese patent medicine, decoction pieces, physicochemical drugs, five drug manufacturing raw materials medicine research institutes.
It accounts for 29.5% of the output value, and the average growth rate of the output value of the latter three industries is 24.6%, which is higher than that of the pharmaceutical manufacturing industry.
The overall growth rate is high, and the average growth rate of pharmaceutical industry output value is raw materials.
The total amount of USD 4 billion accounts for about 30% of the total value of the API industry, with an average growth rate of 20.5%.
Some raw materials are capable of internationalization, and the industrial sector accounts for 5% of the total foreign exchange earned by export commodities.
0%
Zheng Zhimin: Advantage API product category has set some advantages in some fields around the world.
At present, there are 4000 kinds of drugs used in the world, of which 2000 belong to drugs.
According to the production scale, production and sales volume, the product output reaches thousands of tons.
100 grams of trace products: antibiotics, antipyretic and analgesic drugs, central nervous system drugs and vascular drugs of our company.
Anti-tumor drugs and other therapeutic drugs only have special domestic sales and wide application.
Compared with the product chain, it can produce products on a large scale and highlight its own advantages.
China's microbial fermentation and semi-synthesis are at the leading level in the world, both in Europe and in the world.
European API technology is leading, and some developed countries have patents.
Production costs and environmental protection costs are generally higher than the rapid development of India.
India, a competitive country, is similar to me. The economic base and the pharmaceutical industry seem to be.
Walk ahead of me. API only competes with India to swim between supply and demand.
Background of recent trade events
Zheng Zhimin: the relationship between the distribution of API manufacturers and manufacturing industry
I have registered and passed GMP certification, and can produce 1600 pharmaceutical companies.
Semi-enterprise API products are only sold to pharmaceutical companies and top 100 pharmaceutical companies for their own use.
Basically, it can produce varieties for personal use, saying that all enterprises produce raw materials in the API workshop.
Use the export point to cooperate with foreign patent pharmaceutical companies and some pharmaceutical companies to produce raw materials.
Materials and medicines should be used exclusively for the export of production raw materials, and self-made raw materials should be given for export.
Sell the fine chemicals of the API enterprise department to the pharmaceutical industry enterprises.
General production and sales of raw materials and preparations
Compared with developed areas in agriculture and chemical industry, China's API industry is relatively strong.
Hebei, Shandong, Jiangsu, Zhejiang, Guangdong Institute of Grain and Petrochemical Products Pharmaceutical Industry
In some areas, the pharmaceutical industry is relatively developed, and in some areas, the basic industrial conditions of scientific research and talents are superior.
Provide necessary guarantee for pharmaceutical high-tech industry.
Zheng Zhimin: outsourcing and procurement of APIs, APIs, world pharmaceutical professional chemical industry.
Trends meet new development machines.
At present, there are about 4000 kinds of drugs in the world, with fixed scale and frequent transactions.
In thousands of cases, except for several doses, the doses of antitoxin and vitamins are very small.
The output reached a certain economic scale, and some API enterprises turned to functionalization.
Governments should actively control the production equipment and special raw material production lines with the same variety of raw materials.
Lower drug prices and public medical support have prompted pharmaceutical companies to reduce the production of various raw materials.
The shift to targeted procurement has made the API industry gradually move towards the global trend of API specialization.
The industry should include synthesis, fermentation, process release, on-site production management, product marketing, drug research and so on.
Strong technical expertise, high team wisdom and large management scale can reflect high efficiency.
American pharmaceutical companies began to turn to raw material drug procurement earlier.
Overseas, first Europe, then India, now aim.
Enterprises with low cost and excellent technology and equipment must be based on production technology and quality.
Only quality management and target drug management qualifications can keep up with the needs of world industrial development.
The new API deals, and the cooperation between enterprises and cross-companies has gained more management experience.
Innovative concept, a new opportunity for the development of pharmaceutical industry